Prognostic Value of Dobutamine

详细信息    查看全文

• 作者：Jeane M. Tsutsui ; Paulo M.M. Dourado ; S ; ra N.R.S. Falcã ; o ; Magda Figueiredo ; Vitor C. Guerra ; Ant&#xf4 ; nio C.P. Chagas ; Protá ; sio L. daLuz ; José ; A.F. Ramires ; Wilson Mathias Jr.
• 刊名：The American Journal of Cardiology
• 出版年：2008
• 出版时间：15 November 2008
• 年：2008
• 卷：102
• 期：10
• 页码：1291-1295
• 全文大小：264 K

文摘

Although a new protocol of dobutamine stress echocardiography with the early injection of atropine (EA-DSE) has been demonstrated to be useful in reducing adverse effects and increasing the number of effective tests and to have similar accuracy for detecting coronary artery disease (CAD) compared with conventional protocols, no data exist regarding its ability to predict long-term events. The aim of this study was to determine the prognostic value of EA-DSE and the effects of the long-term use of β blockers on it. A retrospective evaluation of 844 patients who underwent EA-DSE for known or suspected CAD was performed; 309 (37 % ) were receiving β blockers. During a median follow-up period of 24 months, 102 events (12 % ) occurred. On univariate analysis, predictors of events were the ejection fraction (p <0.001), male gender (p <0.001), previous myocardial infarction (p <0.001), angiotensin-converting enzyme inhibitor therapy (p = 0.021), calcium channel blocker therapy (p = 0.034), and abnormal results on EA-DSE (p <0.001). On multivariate analysis, the independent predictors of events were male gender (relative risk [RR] 1.78, 95 % confidence interval [CI] 1.13 to 2.81, p = 0.013) and abnormal results on EA-DSE (RR 4.45, 95 % CI 2.84 to 7.01, p <0.0001). Normal results on EA-DSE with β blockers were associated with a nonsignificant higher incidence of events than normal results on EA-DSE without β blockers (RR 1.29, 95 % CI 0.58 to 2.87, p = 0.54). Abnormal results on EA-DSE with β blockers had an RR of 4.97 (95 % CI 2.79 to 8.87, p <0.001) compared with normal results, while abnormal results on EA-DSE without β blockers had an RR of 5.96 (95 % CI 3.41 to 10.44, p <0.001) for events, with no difference between groups (p = 0.36). In conclusion, the detection of fixed or inducible wall motion abnormalities during EA-DSE was an independent predictor of long-term events in patients with known or suspected CAD. The prognostic value of EA-DSE was not affected by the long-term use of β blockers.